{
    "code": "52026649",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026649",
    "time": "2019-10-25 03:03:08",
    "許可證字號": "衛部藥輸字第026649號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/02\/19",
    "發證日期": "105\/02\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202664904",
    "中文品名": "瑞貝塔 點滴靜脈注射液",
    "英文品名": "RAPIACTA for Intravenous Drip Infusion 300mg",
    "適應症": "治療成人及一個月大以上兒童之 A 型及 B 型流感病毒急性感染。",
    "劑型": "27D注射液劑",
    "包裝": "60毫升塑膠軟袋裝 100袋以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "Peramivir hydrate",
    "主製造廠": {
        "申請商名稱": "1410301200  台灣塩野義製藥股份有限公司",
        "申請商地址": "台北市中山區南京東路二段２號４樓",
        "主製造廠": "",
        "製造廠名稱": "FJP0628000  NIPRO PHARMA CORPORATION ISE PLANT FOR SHIONOGI JAPAN"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FJP0937000  NIPRO PHARMA CORPORATION ISE PLANT",
            "製造廠廠址": "1-8, DOSHOMACHI 3-CHOME, CHUO-KU, OSAKA, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "公司"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818005210",
            "成分名稱": "Peramivir hydrate",
            "含量描述": "(eq. to Peramivir......300MG)",
            "含量": "349.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "RAC PIv3-108-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026649&Seq=003&Type=9"
        },
        {
            "title": "Rapiacta soft notice-105-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026649&Seq=004&Type=8"
        }
    ]
}